Showing results (311-320 of 985) with videos related to
Sort By:
Pageof 99
International Pharmacopsychiatry|January 1, 1982
Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical studyW M Petrie, T A Ban, W H Wilson, et al.Journal of Cardiac Failure|September 2, 2014
Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failureJustin L Grodin, Muhammad Hammadah, Yiying Fan, et al.The American Journal of Medicine|August 30, 2008
Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic optionsAshish Aneja, W H Wilson Tang, Sameer Bansilal, et al.Journal of Perinatal Medicine|February 15, 2017
B-type natriuretic peptide and echocardiography reflect volume changes during pregnancyJanet M Burlingame, Kelly Yamasato, Hyeong Jun Ahn, et al.Journal of Cardiac Failure|February 4, 2014
Utilization pattern of mineralocorticoid receptor antagonists in contemporary patients hospitalized with acute decompensated heart failure: a single-center experienceMohammed A Chamsi-Pasha, Matthias Dupont, Wael A Al Jaroudi, et al.Journal of the American College of Cardiology|May 30, 2009
Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular riskW H Wilson Tang, Zeneng Wang, Leslie Cho, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|June 23, 2009
Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibitionZeneng Wang, W H Wilson Tang, Leslie Cho, et al.The American Journal of Cardiology|November 27, 2024
Abbreviated Duke Activity Status Index for Risk Stratification in Heart FailureSilvio Nunes Augusto, Yuping Wu, Thanat Chaikijurajai, et al.Progress in Cardiovascular Diseases|October 23, 2024
Optical coherence tomography angiography in cardiovascular diseaseOluwapeyibomi I Runsewe, Sunil K Srivastava, Sumit Sharma, et al.Current Heart Failure Reports|May 14, 2022
Targeting Myocardial Substrate Metabolism in the Failing Heart: Ready for Prime Time?Salva R Yurista, Shi Chen, Aidan Welsh, et al.Pageof 99